Developing a risk stratification tool for advanced NAFLD fibrosis using routinely measured clinical variables in a diabetes clinic annual review

Hamish Miller; Santo Colosimo; Wenhao Li; Jeremy Cobbold; William Alazawi; David Harman; Guruprasad Aithal; Pinelopi Manousou; Richard Parker; Philip n Newsome; David Sheridan; Kalpana Devalia; John Loy; Jeremy Tomlinson

doi:10.1016/S0168-8278(23)02089-5

Developing a risk stratification tool for advanced NAFLD fibrosis using routinely measured clinical variables in a diabetes clinic annual review

Hamish Miller
, Santo Colosimo
, Wenhao Li
, Jeremy Cobbold
, William Alazawi
, David Harman
, Guruprasad Aithal
, Pinelopi Manousou
, Richard Parker
, Philip n Newsome
, David Sheridan
, Kalpana Devalia
, John Loy
, Jeremy Tomlinson

Peninsula Medical School

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	S708
Journal	J Hepatol
Volume	78
DOIs	https://doi.org/10.1016/S0168-8278(23)02089-5
Publication status	Published - 1 Jun 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0168-8278(23)02089-5

https://linkinghub.elsevier.com/retrieve/pii/S0168827823020895

Cite this

Miller, H., Colosimo, S., Li, W., Cobbold, J., Alazawi, W., Harman, D., Aithal, G., Manousou, P., Parker, R., Newsome, P. N., Sheridan, D., Devalia, K., Loy, J., & Tomlinson, J. (2023). Developing a risk stratification tool for advanced NAFLD fibrosis using routinely measured clinical variables in a diabetes clinic annual review. J Hepatol, 78, S708. https://doi.org/10.1016/S0168-8278(23)02089-5

@article{2c08dab4e6e547e2abfefde4106941c4,

title = "Developing a risk stratification tool for advanced NAFLD fibrosis using routinely measured clinical variables in a diabetes clinic annual review",

author = "Hamish Miller and Santo Colosimo and Wenhao Li and Jeremy Cobbold and William Alazawi and David Harman and Guruprasad Aithal and Pinelopi Manousou and Richard Parker and Newsome, \{Philip n\} and David Sheridan and Kalpana Devalia and John Loy and Jeremy Tomlinson",

year = "2023",

month = jun,

day = "1",

doi = "10.1016/S0168-8278(23)02089-5",

language = "English",

volume = "78",

pages = "S708",

journal = "J Hepatol",

issn = "0168-8278",

publisher = "Elsevier B.V.",

}

Miller, H, Colosimo, S, Li, W, Cobbold, J, Alazawi, W, Harman, D, Aithal, G, Manousou, P, Parker, R, Newsome, PN, Sheridan, D, Devalia, K, Loy, J & Tomlinson, J 2023, 'Developing a risk stratification tool for advanced NAFLD fibrosis using routinely measured clinical variables in a diabetes clinic annual review', J Hepatol, vol. 78, pp. S708. https://doi.org/10.1016/S0168-8278(23)02089-5

TY - JOUR

T1 - Developing a risk stratification tool for advanced NAFLD fibrosis using routinely measured clinical variables in a diabetes clinic annual review

AU - Miller, Hamish

AU - Colosimo, Santo

AU - Li, Wenhao

AU - Cobbold, Jeremy

AU - Alazawi, William

AU - Harman, David

AU - Aithal, Guruprasad

AU - Manousou, Pinelopi

AU - Parker, Richard

AU - Newsome, Philip n

AU - Sheridan, David

AU - Devalia, Kalpana

AU - Loy, John

AU - Tomlinson, Jeremy

PY - 2023/6/1

Y1 - 2023/6/1

U2 - 10.1016/S0168-8278(23)02089-5

DO - 10.1016/S0168-8278(23)02089-5

M3 - Article

SN - 0168-8278

VL - 78

SP - S708

JO - J Hepatol

JF - J Hepatol

ER -